Mounjaro®
Starting from £179.99/mo
Start journey Learn morePanic attacks are not listed as a recognised side effect of Mounjaro (tirzepatide) in the UK prescribing information, but some people do report anxiety-like symptoms, palpitations and a sense of unease, particularly in the early weeks of treatment. Understanding why those sensations arise, and when they need medical attention, is something our prescribers discuss with patients regularly. These are prescription-only medicines, and a GPhC-registered prescriber assesses your full health picture before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The sensations people call a panic attack, racing heart, chest tightness, shortness of breath, sudden dread, can have purely physical roots. Mounjaro slows gastric emptying and suppresses appetite through its dual action on GIP and GLP-1 receptors, and that shift in gut physiology produces a cascade of effects the body can find unfamiliar, especially early in treatment.
Nausea is the most common side effect, particularly after starting or moving to a higher dose. Severe nausea raises heart rate and triggers sweating. If you're already feeling unwell, that cluster of signals can be interpreted by the brain as threat, and the result feels indistinguishable from anxiety. Dizziness and light-headedness, which can follow inadequate hydration when appetite is low, add to that picture.
There is also the question of blood sugar. For people without diabetes, tirzepatide rarely causes hypoglycaemia, but a significant drop in glucose, even within the normal range, produces shakiness, a pounding pulse and the kind of cognitive fog that feeds panic. The NHS medicine page for tirzepatide lists dizziness and heart palpitations among known side effects, and both sit squarely inside a panic-attack symptom profile. So the question isn't always whether Mounjaro caused a panic attack — it's sometimes whether it caused the physical conditions that sparked one.
This is the more nuanced part of the picture. GLP-1 receptors are found not only in the gut and pancreas but in regions of the brain associated with stress regulation, including the amygdala. Research into whether GLP-1 agonists influence mood is ongoing, and the findings are not yet settled enough to draw firm conclusions. What the prescribing information does confirm is that anxiety and mood changes are listed as uncommon adverse reactions to tirzepatide — meaning they occurred in fewer than 1 in 100 participants across the clinical trial programme.
For context, the SURMOUNT clinical programme involved thousands of adults, and the overall safety profile was dominated by gastrointestinal effects rather than psychiatric ones. That said, if you have a personal or family history of anxiety disorder, panic disorder or other mental health conditions, that context belongs in your prescriber assessment. It may not exclude you from treatment, but it shapes how closely your symptoms are monitored.
If you are already prescribed medication for anxiety or depression, the interaction picture matters too, and that is something a prescriber reviews as part of your standard eligibility assessment.
This is the practical question, and it deserves a direct answer. Most anxiety-like episodes on Mounjaro resolve within minutes and leave no lasting trace. A panic attack, frightening as it is, is not medically dangerous. But some symptoms that resemble panic require prompt assessment.
Seek urgent medical help if you experience severe, persistent abdominal pain that spreads to your back, with or without vomiting. That pattern is the recognised warning for acute pancreatitis, which the MHRA highlighted in a safety update for GLP-1 medicines in January 2026. Chest pain that does not resolve quickly, palpitations accompanied by fainting, or any allergic reaction (swelling of the face, throat or tongue) also warrant emergency attention, not reassurance.
On the psychological side, if you notice a sustained low mood, thoughts of self-harm, or anxiety that is present most of the day rather than episodic, tell your prescriber before continuing treatment. The full treatment overview for Mounjaro covers the broader side-effect landscape, and reading the patient information leaflet that comes with your pen is always the right starting point for anything unexpected.
The first step is not to assume. Keep a brief note of when the episode happened, what you had eaten, how much you had drunk, and whether you had recently moved to a new dose. That information gives your prescriber something concrete to work with. A pattern tied to dose increases points in a different direction to episodes that appear between meals on an established dose.
Don't adjust your dose yourself. Tirzepatide is titrated on a schedule for good reason, and changing it independently can make symptom patterns harder to interpret. The practical tips many patients find helpful during the early weeks include staying well hydrated, eating slowly, and not skipping meals entirely just because appetite is low, all of which reduce the physiological triggers that overlap with anxiety symptoms.
If you are considering starting Mounjaro and anxiety is a concern, our clinical team reviews every case individually. You can read more about the prescribers behind that process on our clinical team page. You might also find it useful to look at the broader weight-loss treatment options available, so you can make an informed decision about which approach suits your health profile. For patients curious about how tirzepatide compares in clinical terms, our tirzepatide overview covers the mechanism and evidence in more depth, and those wanting to understand the clinical guidance underpinning prescribing decisions may find our summary of the Mounjaro NICE CKS recommendations a useful reference. And if you are thinking about cost as part of your planning, our Mounjaro price context page explains what a legitimate private prescription typically includes.
When you are ready to speak with a prescriber, you can start that process without any prior appointment. Every consultation is reviewed personally, the same day, by a registered clinician. Speak to our prescribers about whether Mounjaro is the right fit for you, and if you want to get the most from treatment from the outset, our guide to practical Mounjaro hacks for weight loss is worth reading before your first dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.